<p>In this inaugural episode of The UroGist, host Dr. Mike Louie of UroGen Pharma welcomes guest Dr. Katie Murray, Professor at NYU Langone Health as well as the Chief of Urology Service at Bellevue Hospital Center, for an informative chat about personalized treatment, management, and subsequent challenges for low-grade upper tract urothelial cancer (LG-UTUC) patients.</p>

In this inaugural episode of The UroGist, host Dr. Mike Louie of UroGen Pharma welcomes guest Dr. Katie Murray, Professor at NYU Langone Health as well as the Chief of Urology Service at Bellevue Hospital Center, for an informative chat about personalized treatment, management, and subsequent challenges for low-grade upper tract urothelial cancer (LG-UTUC) patients.

Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray

The UroGist is a podcast series from UroGen Pharma, that takes an informative and engaging look at the latest in urologic oncology through enlightening and interesting conversations with leading urologists and other stakeholders. Hosted by Dr. Michael Louie, the SVP of Medical Affairs and Clinical Development at UroGen. The UroGist seeks to provide a more contextualized understanding of advances in the field that are reshaping the treatment landscape for urologic cancers.

Share Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray

Sign up to save your podcasts

Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray

Ep. 01: Treatment Paradigm for Low-Grade Upper Tract Urothelial Cancer with Dr. Katie Murray